Matthew Thompson - 20 Jun 2024 Form 4 Insider Report for Vivos Therapeutics, Inc. (VVOS)

Role
Director
Signature
/s/ Bradford K. Amman as attorney-in-fact for Matthew Thompson
Issuer symbol
VVOS
Transactions as of
20 Jun 2024
Net transactions value
+$9,520
Form type
4
Filing time
28 Jun 2024, 20:53:49 UTC
Previous filing
28 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VVOS Stock Option (Right to Buy) Award $9,520 +4,000 +130% $2.38 7,067 20 Jun 2024 Common Stock 4,000 $2.38 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 20, 2024, the Reporting Person received a grant of 4,000 stock options from the Issuer. One-half vested immediately, one-fourth will vest on September 30, 2024 and one-fourth will vest on December 31, 2024.